Objective: One prospective treatment option for vocal fold scarring is regeneration with an engineered scaffold containing induced pluripotent stem cells (iPS). In the present study, we investigated the feasibility of utilizing an injectable hyaluronic acid (HA) scaffold encapsulated with human-iPS cell (hiPS) for regeneration of vocal folds. Methods: Thirty athymic nude rats underwent unilateral vocal fold injury. Contralateral vocal folds served as uninjured controls. Hyaluronic acid hydrogel scaffold, HA hydrogel scaffold containing hiPS, and HA hydrogel scaffold containing hiPS with epidermal growth factor (EGF) were injected in both vocal folds immediately after surgery. One and 2 weeks after injection, larynges were excised for histology, immunohistochemistry, and fluorescence in situ hybridization (FISH). 
Introduction
Vocal fold scarring after injuries secondary to trauma, surgery, and inflammation post infection remains intractable. 1 In conventional treatments for vocal fold scar, injection of steroids 2 and several types of grafts such as fat tissue, 3 fascia, 4 and perichondrium 5 have been used for the recovery of severely impaired vocal fold mucosa. These treatment approaches are, however, limited of its regenerative capacity and sometimes lead to the further deterioration of voice condition. No consensus has been reached regarding the effective treatment of vocal fold scar. One potential treatment option for this voice disorder is to replace the damaged vocal fold with tissue-engineered materials using regenerative medicine strategies. Regenerative medicine focuses on the repair, replacement, or regeneration of human cells, tissues, or organs to restore impaired function. Regenerative strategies include but are not limited to the use of soluble molecules (eg, growth factors), stem cell transplantation, tissue scaffold, and the reprogramming of cell and tissue types. 6 Our group has investigated an injectable hyaluronic acid (HA) hydrogel scaffold as a carrier for mesenchymal stromal cells (MSCs) for vocal fold scar treatment. 7 Mesenchymal stromal cells have limited ability to proliferate and differentiate for full potential of tissue regeneration. 8 An alternative cell source is embryonic stem cells (ES), also known as pluripotent stem cells. Embryonic stem cells are generated from embryos and can undergo unlimited proliferation and differentiation. 9 Transplant rejection and ethical issues with ES have limited its use for tissue-engineering applications in humans. Another cellular therapy option that has been utilized in regenerative medicine strategies are induced pluripotent stem cells (iPS). These cells were first generated from skin fibroblasts by the introduction of 4 transcription factors, Oct3/4, Sox2, c-Myc, and Klf4. 10 The iPS are capable of unlimited symmetrical self-renewal and thus provide a limitless cell source for tissue-engineering applications. [11] [12] [13] [14] The iPS are obtained from patient-derived somatic cells and thus minimize the risk of rejection after transplantation. 10 Further, iPS have ability to differentiate into any tissue or cell type. Because the vocal folds are composed of heterogeneous tissue types, including epithelium, lamina propria, cartilage, and muscle, the pluripotent capacity of iPS makes them a desirable cell source for vocal fold regenerative treatment. We have previously reported differentiation of iPS that were seeded in a HA hydrogel scaffold 15 into epithelial cells. Differentiated cells from iPS displayed epithelial cell morphology and expressed cytokeratin (CK) 14 epithelial associated protein. However, the vocal fold epithelial differentiation of iPS was only confirmed in vitro. Further in vivo testing is the necessary next step to the eventual translation of iPS for clinical use. 15 The objective of this study was to examine survival, proliferation, and differentiation of human-iPS cells (hiPS) embedded in injectable HA hydrogel scaffold for vocal fold regeneration in an in vivo environment. Three types of injectable materials were tested in this study: (1) HA hydrogel scaffold, (2) HA hydrogel scaffold containing hiPS, and (3) HA hydrogel scaffold containing hiPS with epidermal growth factor (EGF). Our previous work suggested that maximizing hyaluronan levels in the early stages of wound repair may have therapeutic potential for decreasing the incidence of vocal fold scar in the long term. 16 Results showed that HA hydrogel scaffold has similar viscoelastic properties to that of human vocal fold mucosa in vitro 17, 18 and were biocompatible and noninflammatory in vivo. 19 We also reported that the favorable effect of EGF on hiPS co-cultured with human vocal fold fibroblasts (hVFF) in vitro. 15 In this study, we hypothesized that hiPS would generate autologous cells that would be tolerated by immunodeficient animals. We further hypothesized that HA hydrogel with EGF would induce iPS proliferation and differentiation, interacting and influencing the local vocal fold cells that modulate the wound environment immediately after injury, providing prophylactic benefits for improving tissue recovery.
Materials and Methods

Human-Induced Pluripotent Stem Cells Culture
Human-iPS (fibroblast-derived IMR90-4 line, WiCell, Madison, Wisconsin, USA) 20 were cultured on feeder-free surfaces using Matrigel (BD Bioscience, San Jose, California, USA) coated tissue culture dishes with mTeSR1 (StemCell Technologies, Vancouver, British Columbia, Canada) medium, a defined, feeder-free maintenance medium for hiPS. Morphologically identifiable differentiated cells were mechanically removed, and cells were passaged every 6 to 7 days. Passage 54-57 hiPS karyotyped by WiCell were used throughout this investigation.
Preparation of 3 Types of Injectables
Three injectable solutions, HA hydrogel scaffold (gel only), HA hydrogel scaffold containing hiPS (cells and gel), and HA hydrogel scaffold containing hiPS with EGF (cells and gel with EGF), were prepared as follows. The HA hydrogel scaffold, HA-gelatin hydrogel, Glycosil (Glycosan BioSystems, Inc, Salt Lake City, Utah, USA), was developed in conjunction with the Center for Therapeutic Biomaterials at The University of Utah. [21] [22] [23] The scaffold is composed of polyethylene glycol diacrylate (PEGDA)-crosslinked thiol-modified hyaluronic acid (CMHA-S) and thiol-modified gelatin (Gtn-DTPH). Hydrogel was prepared by mixing a 50 mg of CMHA-S in 5 ml deionized water (DG water) (1.0% w/v) and a 10 mg of Gtn-DTPH in 3 ml DG water (0.33% w/v) with a 50 mg of PEGDA in 2 ml DG water (2.5% w/v). The final concentration for each solution was CMHA-S 0.5% (w/v), Gtn-DTPH 0.1% (w/v), and PEGDA 0.5% (w/v).
For hiPS and HA hydrogel, hiPS were suspended in the reconstituted HA hydrogel solution at a density of 2.0 × 10 7 cells per mL. For hiPS and HA hydrogel with EGF injection, EGF (R&D Systems, Minneapolis, Minnesota, USA) at a final concentration of 1 μg/ml was pipetted into cell-gel mixed solution. Hyaluronic acid hydrogel scaffolds similar to ours have shown to permit slow, controlled release of growth factors in tissue transplants. 24 In this study, EGF was loaded in the HA hydrogel scaffold for slow release into the vocal folds over the postinjection period. Further, owning to the limited size of rat vocal folds, the maximum volume of injectable materials was tested as 5 ul without causing excessive tissue bulging that might compromise the airway of the animals. Our pilot work also showed that a total number of 1.0 × 10 5 cells was necessary for the subsequent evaluation of cell retention in the treated vocal folds. A density of 20 million cells per ml were thus formulated in this study.
Surgical Procedure
Animal use protocol was approved by the Institutional Animal Care and Use Committee of the University of Wisconsin-Madison. A total of 30 (10 rats for each treatment group) 9-to 10-week-old male athymic nude (Hsd: RH-Foxn1 rnu rnu/rnu) rats were used as implant recipients.
Athymic nude rats are used as they lack a normal thymus and functionally mature T cells, allowing us to test the possibility of transplant rejection for xenograft implantation. Athymic rats have been suggested as one of the best available approaches for in vivo investigation of graft injection in immunocompromised hosts. 25, 26 Animals were anesthetized by exposure to isofluorane (2% to 3% delivered at 0.8-1.5 L/min) and intraperitoneal injection of 90 mg/kg of ketamine hydrochloride and 9 mg/ kg of xylazine hydrochloride. Intraperitoneal atropine sulfate was used to reduce salivation (0.05 mg/kg). Animals were placed on a custom-made operating platform in near vertical position. Vocal folds were visualized using a custom-fabricated 1 mm diameter steel wire laryngoscope and a 1.9 mm diameter 30° endoscope (Karl Storz Endovision, Inc, Charlton, Massachusetts, USA) connected to an external light source and video monitor. In order to investigate the self-tolerance to a foreign transplant, the left vocal fold served as uninjured controls to evaluate the survival of autologous cell generated by hiPS in the absence of any biological factors owning to the surgery. The right vocal fold was surgically incised with a 25-gauge needle along the membranous portion of the vocal fold from epithelium layer to lamina propria layer without removing the epithelium. Immediately after the incision, a 26-gauge needle and a microliter syringe (Hamilton Co, Reno, Nevada, USA) were used to inject a volume of 5 μL HA hydrogel solution only, HA hydrogel solution with hiPS, or HA hydrogel solution with hiPS and EGF into both injured and uninjured vocal folds. For both hiPS injection groups, approximate 1.0 × 10 5 hiPS were contained in each 5 ul of cell-gel solution.
Animals were euthanized 1 or 2 weeks after injection. Larynges were excised for histology, immunohistochemistry, and fluorescence in situ hybridization (FISH). Three of the 30 nude rats were euthanized unexpectedly before the 2-week follow-up endpoint due to complications related to anesthesia or metal allergy to the surgical instruments. A total of 27 animals (9 rats each treatment group; 5 and 4 animals from the 1-and 2-week groups, respectively) were used for data analysis.
Histology/Immunohistochemistry
Larynges were fixed with 10% formalin and embedded in paraffin. Paraffin-embedded tissues were cut at a thickness of 5 μm per section for hematoxylin and eosin (H&E), Elastic van Gieson (EVG), trichrome staining, and immunohistochemical analyses. The H&E staining was used for morphological analysis, elastin content was visualized with EVG staining, and trichrome staining was used to evaluate collagen content. Both EVG and trichrome stains were analyzed qualitatively for density of labeling relative to uninjured control tissue. Immunohistochemical staining was performed using an indirect streptavidin-biotin immunoperoxidase method. Detection of pancytokeratin (CK), alpha 1 fetoprotein (AFP), and placental alkaline phosphatase (PLAP) were performed by staining with antipan cytokeratin primary mouse monoclonal antibody (1:250 dilution, ab6401; Abcam, Inc, Cambridge, Massachusetts, USA), anti-alpha 1 fetoprotein primary rabbit monoclonal antibody (1:250 dilution, ab133617: Abcam, Inc), and anti-placental alkaline phosphatase (PLAP) primary rabbit monoclonal antibody (1:500 dilution, ab133602; Abcam, Inc), respectively. The panCK staining was used to evaluate epithelial differentiation. The AFP and PLAP staining were used to evaluate germ cell tumor differentiation. Secondary antibodies, ImmPress Reagent anti-rabbit (MP-7401, Vector Laboratories, Burlingame, California, USA) or ImmPress Reagent antimouse (MP-7402, Vector Laboratories), were applied for 30 minutes, respectively. Antigen retrieval using sodium citrate and heat was performed and primary antibodies were applied overnight at 4°C. Labeling was detected using horseradish peroxidase and visualized with diaminobenzidine (DAB) prior to counterstaining with hematoxylin. Slides were observed using a microscope (E600, Nikon, Melville, New York, USA). All images were taken with a digital camera (DP71, Olympus, Tokyo, Japan) and evaluated for histopathological findings and scar formation by an independent pathologist, who was blinded to the experimental condition of images.
FISH Analysis
Detection of human cells with FISH analysis was performed. Slides were deparaffinized in Citrisolv (Fisher Scientific, Madison, Wisconsin, USA) and rehydrated in ethanol, followed by sequential treatment with 0.2N HCl, 1M sodium thiocyanate, Protease I (Abbott Molecular, Downers Grove, Illinois, USA), 10% formalin, and dehydrating ethanol series (70%, 85%, and 95%). In situ genomic DNA and probe were denatured simultaneously by heating at 73°C for 2 minutes using a ThermoBrite instrument (Abbott Molecular). Hybridization was performed overnight at 37°C with the human-specific CEP4(D4Z1)/ CEP10(D10Z1)/CEP17(D17Z1) probe mixture (Abbott Molecular), which tested negative in non-hiPS injected rat vocal folds, ensuring that the probe is not cross-reacting with cells of rat origin. Finally, the slides were mounted with Vectashield containing DAPI (Vector Laboratories Inc). the FISH images were analyzed the presence of hiPS by a clinical cytogenetist, who was blinded to the experimental conditions of images.
Statistical Analysis
Retention of hydrogel in rat vocal folds was compared between 1 and 2 weeks using a chi-square test. The presence of scar, which was evaluated by the densities of collagen and elastin, was compared between the groups of hiPS-only and hiPS and EGF groups for each time point using chi-square tests. All analyses were carried out using SAS 9.2 (SAS Institute, Cary, North Carolina, USA) software. A p-value <.05 was considered statistically significant.
Results
Existence of Hydrogel
Hyaluronic acid hydrogel was confirmed in 25 of 27 nude rat larynges (Table 1 ; Figures 1-3) . One week following injection, HA hydrogel was observed in both sides of the vocal folds in all animals with the exception of 1 animal from the hiPS-HA hydrogel with EGF group. At 2 weeks following injection, results are consistent with uninjured vocal folds across all 3 treatment groups, and HA hydrogel was presented in 75% of animals for each treatment group. For injured vocal folds, HA hydrogel was found in 25% of the animals for the HA-hydrogel only group and 50% of animals for each hiPS injection group. There were significant differences in hydrogel retention between the 2 time points investigated; at 1 week, HA hydrogel was confirmed in 29 of 30 vocal folds (96.67%) compared to at 2 weeks 14 of 24 vocal fold (58.33%) having HA hydrogel (P = .0005) ( Table 1) .
Retention of hiPS-Derived Cells
The hiPS-derived cells, which are loose collections of intermediate to large cells with condensed chromatin, smooth nuclear contours, and moderate to large amounts of agranular amphophilic cytoplasm, were observed in 13 of 18 samples (Table 1; Figures 2-3) . At 1 week following injection, all animals in the hiPS HA hydrogel only group showed hiPS-derived cells in both vocal folds. The incidence of hiPS-derived cells was lower in the hiPS HA hydrogel with EGF: 80% and 60% for the injured and uninjured vocal folds, respectively. For 2 weeks following injection, hiPSderived cells were observed in 50% of vocal folds in the hiPS HA hydrogel only group. With the addition of EGF, hiPS-derived cells were observed in 50% and 75% of injured and noninjured vocal folds, respectively.
Existence of Scar
Vocal fold scar, which was evaluated by the densities of collagen and elastin based on EVG and Trichrome staining, respectively, was observed in 18 of 27 injured samples (Table 1 ; representative samples in Figure 4 ). At 1 and 2 weeks after HA hydrogel injection without EGF, 7 of 9 (77.8%) injured vocal fold demonstrated fibrosis. At 1 and 2 weeks after HA hydrogel injection with EGF, 4 of 9 (44.8%) injured vocal fold showed fibrosis. Specifically, for groups of HA hydrogel only and hiPS HA hydrogel only, scars were observed in 80% and 75% of injured vocal folds at 1 and 2 weeks after injection, respectively. The percentage of scar dropped to 40% and 50% at 1 and 2 weeks following the injection of hiPS HA hydrogel with EGF. The HA hydrogel with EGF group showed less scar compared to that of HA hydrogel without EGF group, but the results were not statistically significant (p = .08).
Immunohistochemical Analysis for Implanted Cell Identity
Morphological analysis suggested a mixed germ cell-like tumor was characterized in 1 of the 18 larynges ( Figures  5A, 5B ). Immunohistochemical analyses with AFP and PLAP were performed to confirm the characteristic of tumor that looked like germ cell tumor in rat vocal folds. Expression of AFP and PLAP markers was not detected ( Figures 5C, 5D ) in any samples. To confirm the epithelial differentiation of hiPS with EGF in the vocal folds, immunohistochemical analysis with panCK was performed. In the hiPS colony containing epithelium-like tissue, expression of panCK was not detected (Figures 6A, 6B) .
FISH Analysis for Confirmation of Implanted Human Cells
Persistence of human cells in injured and uninjured hiPS injected vocal folds were further confirmed with the use of FISH and fluorescence-labeled human reference DNA. The FISH-positive cells were detected in the vocal folds of all representative samples 2 weeks after hiPS injection ( Figure  7A ), whereas no FISH signals were detected in injection control samples ( Figure 7B ). Results suggested that implanted hiPS could retain in the host vocal fold tissue up to 2 weeks after injection.
Discussion
A number of studies have investigated the possibility of usage of stem cells such as MSC and ES lines as new cell sources for vocal fold regenerative medicine. 7, 27, 28 These studies have shown that MSC and ES have the potential for vocal fold lamina propria regeneration. Although MSCs are safe, these cells have limited ability to proliferate and differentiate. 8 On the other hand, ES are capable of unlimited proliferation and differentiation into any cell or tissue type but with transplant rejection and ethical issues. Alternatively, iPS have the capability of unlimited symmetrical selfrenewal with less ethical and transplant rejection concerns, making these cells as an appealing option for cell-based tissue regeneration. 10, 20 Numerous studies have demonstrated successful survival of iPS in various organs, brain, 29 trachea, 13, 14 subcutaneous tissue, 30 and cochlea. 31 Except for ES cell implantation, to our best knowledge, no investigation has been published utilizing pluripotent stem cells for vocal fold tissue regeneration to date.
The current study demonstrated the feasibility and the survival of injected hiPS in HA hydrogel in athymic rat vocal folds up to 2 weeks following injection as shown by the appearance of H&E-stained colonies in the vocal folds and detection of human cells with FISH analysis, suggesting the hiPS longevity in vocal fold tissue. Although athymic nude rats are the viable option for in vivo study of graft injection, we recognized that no systematic studies have been carried out to study the histological and functional characteristics of vocal fold scar in athymic versus immunocompetent rats. This study, however, provided secondary information that athymic rats displayed similar histopathology such as the increase of collagen and granulation tissue after 1 week and 2 weeks of surgical injury, corroborating the results from our previous and other vocal fold scarring studies using immunocompetent animals. 7, [32] [33] [34] [35] Numerous studies have investigated the use of hydrogels such as gelatin hydrogel 36 and collagen hydrogel 37 as a scaffold to maintain cells and growth factors. Hyaluronic acid hydrogel has been documented to be one such suitable material for vocal folds tissue engineering. 21, 23, 38, 39 However, no reports have demonstrated the use of HA hydrogel as an injectable scaffold for hiPS implantation into the vocal folds. In these reports, HA hydrogel were injected into the vocal folds either immediately after the surgery or several weeks after. Technically, immediate injection of HA hydrogel after the surgery is challenging. Hyaluronic acid hydrogel leakage can occur through the surgical incision if the gelation of the injected material is not timely. In the current study, HA hydrogel was observed in 23 of 27 noninjured vocal folds and 20 of 27 injured vocal folds up to 2 weeks post injection. No significant differences in gel retention were found between groups. Our results suggested the feasibility of injecting engineered materials immediately after the surgery and the formulation of our injectable material makes it a plausible carrier to improve the delivery, release, and residency of cells or growth factors.
The hypothesis that EGF signaling would influence cell proliferation and differentiation in vivo was not supported in the present in vivo study. Our previous in vitro study showed that hiPS cultivated with EGF had significantly decreased levels of Oct 3/4, indicating differentiation. 15 Immunofluorescence staining revealed the presence of pancytokeratin and cytokeratin 13 vocal fold epithelium associated proteins in hiPS EGF culture, suggestive of epithelial differentiation. 15 However, in the current study, epithelial-related protein was not detected in our hiPS with EGF colonies (Figure 6 ). It is well known that several ligands such as EGF and transforming growth factor-α can bind the EGF receptor (EGFR) and regulates epithelial proliferation and differentiation. 40 Mice lacking EGFR suffer from impaired epithelial development in several organs. 41 However, the aforementioned results suggested that an in vivo environment surrounding hiPS is different from the in vitro environment.
We also hypothesized positive effects of EGF to mitigate tissue fibrosis in injured vocal folds. The EGFR is reported to acts as a potent mitogen not only for epithelial but also for mesenchymal cells. 42, 43 The signaling pathway of EGFR is suggested to play important roles in inflammation and repair, such as decreasing inflammatory cell infiltration and TGF-β expression. [44] [45] [46] Clinical studies have shown that recovery of ulcer wounds is promoted by the application of EGF gel dressing. 47, 48 Our results showed that the number of animals displaying postsurgical scar was less in the group of HA hydrogel with hiPS and EGF than that of HA hydrogel with hiPS only group, suggesting potential anti-fibrotic effects of EGF in injured vocal folds. That being said, given the current study design, the reduction of scar formation might contribute to the synergistic effects of EGF on both hiPS and resident cells in the vocal folds. Further investigation is warranted to include an additional group of HA hydrogel with EGF only to characterize the effects of EGF on cells residing such as fibroblasts in the vocal fold lamina propria.
In the present study, the measured effects of iPS on vocal fold scar prevention were inconsistently observed in our animals with hiPS only implantation. Conflicting results of iPS's antifibrotic functions are also reported in myocardial infarction models. [49] [50] [51] [52] To elucidate the mechanistic effects of iPS for scar prevention, further studies should be implemented. New strategies such as induction of differentiation into precursor or mature cells before the implantation and/ or addition of other growth factors might be needed to effectively mitigate scar formation using hiPS. A tumor was confirmed in 1 of the 18 rat larynges. This tumor displayed pathological characteristics of yolk-sac and embryonal cell tumor, suggesting an identity of a germ cell tumor. However, markers of germ cell tumor differentiation, namely, AFP and PLAP, were not detected in the sample. One speculation is that this tumor did not differentiate enough to express germ cell associated proteins. A long-term observation after implantation of iPS will be required to confirm the germ cell tumor associated proteins.
Furthermore, the clinical diagnosis of vocal fold scarring in human is evaluated based on the movement of mucosal wave under stroboscopic light or laryngeal high-speed videoendoscopy. However, given the small size of rat larynges, no reliable imaging methods are available to quantify the vocal fold mucosal movement in rats. We thus opted to categorize the variable of scarring based on its histological presentation in this first study of investigating hiPS in the vocal folds. Larger animals such as rabbits will be used for our future investigation to better quantify vocal fold scarring.
Conclusions
Survival of injected hiPS in HA hydrogel was confirmed in the rat vocal folds. Hyaluronic acid hydrogel with EGF decreased scar formation in injured vocal folds. The presence of tumor was noted in 1 of the 18 larynges. Our study suggested that hiPS with injectable HA hydrogel would be feasible as a strategy for the regeneration of injured vocal folds. Further work is essential to focus on the differentiation of hiPS and the investigation of safety for future clinical applications.
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